1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址：

https://www.sciepublish.com/journals/biobreeding

4、投稿系统：

https://www.sciepublish.com/my/submitting/journal/73

5、官网邮箱：biobreeding@sciepublish.org

6、出刊日期：季刊，一年出版四期。

7、主办单位微信公众号：岳麓山实验室

2026年3月12日星期四

Guide for Authors

【官网信息】

1. Before Submission

Before you submit to Biobreeding, please go through the following information carefully.

1.1. Submission Checklist

Please:

read the Aims & Scope to check if your manuscript is suitable for this journal;

use

the Microsoft Word template to prepare your manuscript; If you prefer

to prepare references with bibliography software, download the EndNote

Style;

make

sure that issues about research and publication ethics, conflicts of

interest, author contributions, data and materials availability, and

funding have been clarified appropriately;

ensure that all authors have approved the content of the submitted manuscript;

all manuscripts must be submitted online through SCIEPublish manuscript platform.

1.2. Open Access, License and Copyright

Biobreeding

is a peer-reviewed, fully open access journal. All articles published

with open access will be immediately and permanently free for everyone

to read, download, copy, and distribute as defined by Creative Commons

CC BY 4.0 license. The copyright of the published paper is retained by

authors.

1.3. Article Charge Processing (APC)

The

Article Processing Charge (APC) is $500 per article (plus VAT if

applicable). The APC will be fully waived for authors publishing in

Biobreeding before 31 December 2026. There are no additional charges

based on color, length, figures, or other items.

2. Submission Preparation

2.1. Types of Article

Manuscripts

submitted to Biobreeding should neither be published previously nor be

under consideration for publication in another journal. The main article

types are as follows:

Original

Research Article (5000-10000 words): Original research manuscript

reports scientifically sound experiments and provides a substantial

amount of new information with enough related tables and/or figures and a

clear structure to contain Introduction, Material and Methods, Results,

Discussion and Conclusions.

Review

paper (5000-15000 words): Review should provide a complete and balanced

overview on the latest progress in a given area of research.

Communication

(2000-5000 words): Communication is a short research article usually

claiming certain results, which present original and significant

material for rapid dissemination.

Case

Report (2000-5000 words): Case report usually describes an unusual or

novel occurrence and as such, remain one of the cornerstones of medical

progress and provide many new ideas in medicine.

Other

article types often invited by Editors are also considered, such as

Editorial, Perspective, Commentary, Opinion, Letter to Editor, and so

on. Details can be found at For Authors.

2.2. Article Structure

2.2.1. Title Page

Title.

Concise and informative. Titles are often used in information-retrieval

systems. Avoid abbreviations and formulae where possible.

Author

names and affiliations. Please clearly indicate the given name(s) and

family name(s) of each author and check that all names are accurately

spelled. You can add your name between parentheses in your own script

behind the English transliteration. Present the authors' affiliation

addresses (where the actual work was done) below the names. Indicate all

affiliations with a superscript Arabic numerals immediately after the

author's name and in front of the appropriate address. Provide the full

postal address of each affiliation, including the country name and, if

available, the insitutional E-mail address of each author.

Corresponding

author. Clearly indicate who will handle correspondence at all stages

of refereeing and publication, also post-publication. This

responsibility includes answering any future queries about Methodology

and Materials. Ensure that the insitutional E-mail address is given and

that contact details are kept up to date by the corresponding author.

ORCID. All authors are encouraged to provide ORCID information when submitting.

Present/permanent

address. If an author has moved since the work described in the article

was done, or was visiting at the time, a "Present address" (or

"Permanent address") may be indicated as a footnote to that author's

name. The address at which the author actually did the work must be

retained as the main, affiliation address. Superscript symbols are used

for such footnotes.

Publication history. The submission date, revised date, accepted date, and published date will be included in this part.

Abstract.

A concise and structured abstract is required. The abstract should

state briefly the purpose of the research, the main methods or

treatments applied, the principal results and major conclusions. The

abstract should be an objective representation of the article and it

must not contain results that are not presented and substantiated in the

main text and should not exaggerate the main conclusions. An abstract

is often presented separately from the article, so it must be able to

stand alone. For this reason, References should be avoided. Also,

non-standard or uncommon abbreviations should be avoided, but if

essential they must be defined at their first mention in the abstract

itself. A single paragraph of about 200 words maximum.

Graphical

abstract. The graphical abstract is optional, but it draws more

attention to the online article. The graphical abstract should summarize

the contents of the article in a concise, pictorial form designed to

capture the attention of a wide readership. Graphical abstract should be

submitted as a separate file in the online submission system. Image

size: Please provide an image with a minimum of 374 × 990 pixels (h × w)

and high resolution of 300 dpi. Preferred file types: TIFF, PNG or MS

Office files.

Keywords. provide a maximum of 8 keywords, avoiding general and plural terms and multiple concepts.

Copyright.

Authors retain copyright of their works through Creative Commons CC BY

4.0 license that clearly states how readers can copy, distribute, and

use their attributed research, free of charge. A declaration "©The

Author(s) Year." will be added to each article.

2.2.2. Main text

Introduction.

State the objectives of the work and provide an adequate background,

avoiding a detailed literature survey or a summary of the results.

Material

and Methods. Provide sufficient details to allow the work to be

reproduced by an independent researcher. Methods that are already

published should be summarized, and indicated by a reference. If quoting

directly from a previously published method, use quotation marks and

also cite the source. Any modifications to existing methods should also

be described.

Results.

Results should be clear and concise. Each Figure, Table, Scheme and

supplementary information with a short and concise caption should be

inserted into the main text close to their first citation and must be

numbered following their number of appearance (Figure 1, Scheme I, Table

1, etc.).

Discussion.

This should explore the significance of the results of the work, not

repeat them. A combined Results and Discussion section is often

appropriate. Avoid extensive citations and discussion of published

literature.

Conclusions.

The main conclusions of the study may be presented in a short

Conclusions section, which may stand alone or form a subsection of a

Discussion or Results and Discussion section.

2.2.3. Back Matter

Supplementary.

This refers to the supporting information, such as additional images,

data, audios or videos. They should be cited in the main text in numeric

order (e.g., Figure S1, Figure S2, Table S1, Table S2, Video S1, etc.).

The style of supplementary figures or tables should be the same

requirements as figures or tables in main text. Videos and audios should

be prepared in English, and limited to a size of 500 MB. It will be

named as Figure S1: title; Table S1: title; Video S1: title, etc.

Appendices.

If there is more than one appendix, they should be identified as A, B,

etc. Formulae and equations in appendices should be given separate

numbering: Eq. (A.1), Eq. (A.2), etc. Similarly for tables and figures:

Table A.1; Fig. A.1, etc.

Acknowledgments.

The acknowledgement section can be used to thank anyone important in

the publication of the work who does not qualify for authorship. This

may include administrative and technical support, or donations in kind

(e.g., materials used for experiments).

Author

Contributions. For research articles with several authors, a short

paragraph specifying their individual contributions must be provided.

The following statements should be used "Conceptualization, X.X. and

Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and

Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data

Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing –

Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.;

Project Administration, X.X.; Funding Acquisition, Y.Y.”, please turn to

the CRediT taxonomy for the term explanation.

Ethics

Statement. Interventionary studies involving animals or humans, and

other studies that require ethical approval, must list the authority

that provided approval and the corresponding ethical approval code in

this section. Please add “The study was conducted according to the

guidelines of the Declaration of Helsinki, and approved by the

Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE

(protocol code XXX and date of approval).” OR “Ethical review and

approval were waived for this study, due to REASON (please provide a

detailed justification).” OR “Not applicable” for studies not involving

humans or animals.

Informed

Consent Statement. Any research article describing a study involving

humans should contain this statement. Please add “Informed consent was

obtained from all subjects involved in the study.” OR “Patient consent

was waived due to REASON (please provide a detailed justification).” OR

“Not applicable” for studies not involving humans.

Data

Availability Statement. The statement is required for all original

articles which informs readers about the accessibility of research data

linked to a paper and outlines the terms under which the data can be

obtained.

Funding.

All sources of funding of the study should be disclosed. Please add:

“This research received no external funding” or “This research was

funded by [name of funder] grant number [xxx]” and “The APC was funded

by [XXX]” in this section. Check carefully that the details given are

accurate and use the standard spelling of funding agency names at

https://search.crossref.org/funding, any errors may affect your future

funding.

Declaration

of Competing Interest. All authors must disclose any financial and

personal relationships with other people or organizations that could

inappropriately influence (bias) their work. Examples of potential

conflicts of interest include employment, consultancies, stock

ownership, honoraria, paid expert testimony, patent

applications/registrations, and grants or other funding. If there are no

interests to declare, please use the sentence: “The authors declare

that they have no known competing financial interests or personal

relationships that could have appeared to influence the work reported in

this paper”.

References.

References must be numbered in order of appearance in the text

(including citations in tables and legends) and listed individually at

the end of the manuscript. In the text, reference numbers should be

placed as [XX]. If there are 6 or less authors in one reference, please

list all authors’ names in the Reference part. If there are more than 6

authors for one reference, please use “et al.” following the sixth

author’s name.

2.3. Reference Formatting

Reference to a journal publication:

Author 1 AB, Author 2 CD. Title of the article. Abbreviated Journal Name Year, Volume, page range.

Reference to a book:

Author 1 A, Author 2 B. Book Title, 3rd ed.; Publisher: Publisher Location, Country, 2008; pp. 154–196.

Reference to a chapter in an edited book:

Author

1 A, Author 2 B. Title of the chapter. In Book Title, 2nd ed.; Editor 1

A, Editor 2 B, Eds.; Publisher: Publisher Location, Country, 2007;

Volume 3, pp. 154–196.

Reference to an unpublished work:

Author

1 AB, Author 2 C. Title of Unpublished Work. Abbreviated Journal Name

year, phrase indicating stage of publication (submitted; accepted; in

press).

Reference to a patent:

Patent Owner 1; Patent Owner 2; et al. Title of Patent. Patent Number, Date (Day Month Year, the Application granted date).

Reference to a conference report/abstract:

Author

1 AB, Author 2 CD, Author 3 EF. Title of Presentation. In Proceedings

of the Name of the Conference, Location of Conference, Country, Date of

Conference (Day Month Year).

Reference to a thesis:

Author 1 AB. Title of Thesis. Level of Thesis, Degree-Granting University, Location of University, Country, Date of Completion.

Reference to website information:

Title of Site. Available online: URL (accessed on Day Month Year).

Journal abbreviations can be referred to the List of Title Word Abbreviations.

......

更多详见：

https://www.sciepublish.com/journals/biobreeding/instructions